HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

retigeric acid B

from a lichen, Lobaria kurokawae Yoshim; structure in first source

Also Known As:

RAB cpd

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Triterpenes: 2493
      - retigeric acid B: 5

Experts

1.	Young, Charles Y F: 4 articles (09/2013 - 12/2010)
2.	Liu, Yongqing: 2 articles (03/2018 - 08/2013)
3.	Liu, Yong-qing: 2 articles (09/2013 - 12/2010)
4.	Lou, Hong-xiang: 2 articles (09/2013 - 12/2010)
5.	Yuan, Hui-qing: 2 articles (09/2013 - 12/2010)
6.	Guo, Yanxia: 1 article (03/2018)
7.	Li, Juan: 1 article (03/2018)
8.	Lin, Zhaomin: 1 article (03/2018)
9.	Sun, Deqing: 1 article (03/2018)
10.	Wang, Rongmei: 1 article (03/2018)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 03/01/2018 - "Retigeric acid B (RAB), a natural compound isolated from lichen, has been demonstrated to inhibit cell growth and promote apoptosis in prostate cancer (PCa) cells. " 09/01/2013 - "Retigeric acid B-induced mitophagy by oxidative stress attenuates cell death against prostate cancer cells in vitro." 01/01/2012 - "Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo." 03/01/2018 - "Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells." 09/01/2013 - "Retigeric acid B (RAB), a pentacyclic triterpenic acid from Lobaria kurokawae Yoshim, has been found to induce apoptosis in prostate cancer cells. "
2.	Neoplasms (Cancer) 08/28/2013 - "Retigeric acid B (RB) has been reported to exhibit its anti-tumor activity in vitro and in vivo. "

Related Drugs and Biologics

1.	Acids
2.	Topoisomerase II Inhibitors
3.	Cisplatin (Platino)
4.	Antineoplastic Agents (Antineoplastics)
5.	Androgens